Annual Operating Margin
-34.49%
+71.33%+67.41%
31 December 2023
Summary:
Intra-Cellular Therapies annual operating profit margin is currently -34.49%, with the most recent change of +71.33% (+67.41%) on 31 December 2023. During the last 3 years, it has risen by +991.78% (+96.64%). ITCI annual operating margin is now at all-time high.ITCI Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-22.18%
-4.99%-29.03%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly operating profit margin is currently -22.18%, with the most recent change of -4.99% (-29.03%) on 30 September 2024. Over the past year, it has increased by +1.44% (+6.10%). ITCI quarterly operating margin is now -53.28% below its all-time high of -14.47%, reached on 31 March 2024.ITCI Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Operating Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +67.4% | +6.1% |
3 y3 years | +96.6% | +93.8% |
5 y5 years | - | - |
ITCI Operating Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +96.6% | -53.3% | +93.8% |
5 y | 5 years | at high | +96.6% | -53.3% | +99.6% |
alltime | all time | at high | +100.0% | -53.3% | +100.0% |
Intra-Cellular Therapies Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -22.18%(+29.0%) |
June 2024 | - | -17.19%(+18.8%) |
Mar 2024 | - | -14.47%(-44.2%) |
Dec 2023 | -34.49%(-67.4%) | -25.93%(+9.8%) |
Sept 2023 | - | -23.62%(-44.9%) |
June 2023 | - | -42.84%(-16.1%) |
Mar 2023 | - | -51.08%(-5.8%) |
Dec 2022 | -105.82%(-69.7%) | -54.23%(-29.9%) |
Sept 2022 | - | -77.40%(-51.5%) |
June 2022 | - | -159.65%(-23.6%) |
Mar 2022 | - | -209.07%(-38.0%) |
Dec 2021 | -349.65%(-65.9%) | -337.06%(-5.8%) |
Sept 2021 | - | -357.88%(-1.6%) |
June 2021 | - | -363.77%(+6.5%) |
Mar 2021 | - | -341.61%(-30.9%) |
Dec 2020 | -1026.27% | -494.47%(-34.9%) |
Sept 2020 | - | -759.12%(-78.0%) |
June 2020 | - | -3458.22%(-37.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | -5562.00%(-99.1%) |
Dec 2017 | -41.73 K%(+16.7%) | -642.18 K%(+731.2%) |
Sept 2017 | - | -77.26 K%(+376.1%) |
June 2017 | - | -16.23 K%(-44.3%) |
Mar 2017 | - | -29.13 K%(+1.7%) |
Dec 2016 | -35.76 K%(-89.6%) | -28.64 K%(-95.9%) |
Sept 2016 | - | -691.99 K%(+4911.4%) |
June 2016 | - | -13.81 K%(-63.5%) |
Dec 2015 | -345.13 K%(+5998.6%) | - |
June 2015 | - | -37.80 K%(-94.4%) |
Mar 2015 | - | -675.74 K%(+1495.0%) |
Dec 2014 | -5659.20%(+489.7%) | -42.37 K%(+710.5%) |
Sept 2014 | - | -5227.39%(+148.5%) |
June 2014 | - | -2103.46%(-22.8%) |
Mar 2014 | - | -2726.35%(+180.9%) |
Dec 2013 | -959.69%(+82.4%) | -970.70%(+35.5%) |
Sept 2013 | - | -716.42% |
Dec 2012 | -526.09% | - |
FAQ
- What is Intra-Cellular Therapies annual operating profit margin?
- What is the all time high annual operating margin for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual operating margin year-on-year change?
- What is Intra-Cellular Therapies quarterly operating profit margin?
- What is the all time high quarterly operating margin for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly operating margin year-on-year change?
What is Intra-Cellular Therapies annual operating profit margin?
The current annual operating margin of ITCI is -34.49%
What is the all time high annual operating margin for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual operating profit margin is -34.49%
What is Intra-Cellular Therapies annual operating margin year-on-year change?
Over the past year, ITCI annual operating profit margin has changed by +71.33% (+67.41%)
What is Intra-Cellular Therapies quarterly operating profit margin?
The current quarterly operating margin of ITCI is -22.18%
What is the all time high quarterly operating margin for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly operating profit margin is -14.47%
What is Intra-Cellular Therapies quarterly operating margin year-on-year change?
Over the past year, ITCI quarterly operating profit margin has changed by +1.44% (+6.10%)